Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Preston J Ngo"'
Autor:
Sarsha Yap, Emily He, Sam Egger, David E Goldsbury, Jie-Bin Lew, Preston J Ngo, Joachim Worthington, Hannah Rillstone, John R Zalcberg, Jeff Cuff, Robyn L Ward, Karen Canfell, Eleonora Feletto, Julia Steinberg
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Colorectal cancer is the third most diagnosed cancer globally and the second leading cause of cancer death. We examined colon and rectal cancer treatment patterns in Australia. Methods From cancer registry records, we identified 1
Externí odkaz:
https://doaj.org/article/e71f2531479c4192a19268b876edc3ce
Autor:
Marianne F Weber, Preston J Ngo, Emily Banks, Julia Steinberg, David E Goldsbury, Paul Grogan, Karen Canfell
Publikováno v:
Public Health Research & Practice, Vol 32, Iss 4 (2022)
Objective: Over the 15 years since the 45 and Up Study (the Study) was established, researchers have harnessed its capacity for enabling rigorous, comprehensive investigation of cancer causes, care, and outcomes. For the first time in Australia, the
Externí odkaz:
https://doaj.org/article/a141b848631a4f91b01681ac974dffd2
Autor:
Sonya Cressman, Marianne F. Weber, Preston J. Ngo, Stephen Wade, Silvia Behar Harpaz, Michael Caruana, Alain Tremblay, Renee Manser, Emily Stone, Sukhinder Atkar-Khattra, Deme Karikios, Cheryl Ho, Aleisha Fernandes, Jing Yi Weng, Annette McWilliams, Renelle Myers, John Mayo, John Yee, Ren Yuan, Henry M Marshall, Kwun M Fong, Stephen Lam, Karen Canfell, Martin C Tammemägi
Publikováno v:
Lung Cancer. 176:38-45
Using risk models as eligibility criteria for lung screening can reduce race and sex-based disparities. We used data from the International Lung Screening Trial(ILST; NCT02871856) to compare the economic impact of using the PLCOm2012 risk model or th
Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods
Autor:
Preston J. Ngo, Sonya Cressman, Silvia Behar-Harpaz, Deme J. Karikios, Karen Canfell, Marianne F. Weber
Publikováno v:
Lung Cancer. 166:122-131
Lung cancer screening with low-dose computed tomography (LDCT) in high-risk populations has been shown in randomised controlled trials to lead to early diagnosis and reduced lung cancer mortality. However, investment into screening will largely depen
Autor:
Preston J. Ngo, Stephen Wade, Pavla Vaneckova, Silvia Behar Harpaz, Michael Caruana, Sonya Cressman, Martin Tammemagi, Deme Karikios, Karen Canfell, Marianne F Weber
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 169
Trial-based, risk-targeted lung cancer screening with low-dose computed tomography has been shown to reduce lung cancer mortality but implementation may depend on favourable cost-effectiveness evaluations where quality-adjusted life-years are a key m
Autor:
Silvia Behar Harpaz, Marianne F. Weber, Stephen Wade, Preston J. Ngo, Pavla Vaneckova, Peter E. A. Sarich, Sonya Cressman, Martin C. Tammemagi, Kwun Fong, Henry Marshall, Annette McWilliams, John R. Zalcberg, Michael Caruana, Karen Canfell
Publikováno v:
SSRN Electronic Journal.
Background A national, lung cancer screening programme is under consideration in Australia, and we assessed cost-effectiveness using updated data and assumptions. Methods We estimated the cost-effectiveness of lung screening by applying screening par
Autor:
Xue Qin Yu, Mei Ling Yap, Elvin S. Cheng, Preston J. Ngo, Pavla Vaneckova, Deme Karikios, Karen Canfell, Marianne F. Weber
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 17(5)
Women tend to survive a lung cancer diagnosis longer than men; however potential drivers of this sex-related disparity remain largely elusive. We quantified factors related to sex differences in lung cancer survival in a large prospective cohort in A